Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$822.2K
12.20K shares
What this filing means
SCOTT RANDAL W. plans to sell 12.20K shares of BRIDGEBIO PHARMA, INC. valued at approximately $822.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/24/2026ACC: 0001950047-26-006457
12.20K
Shares to sell
$822.2K
Approx. market value
2.20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
6/20/2026
2.20KTotal acquired2.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/20/2026 | Restricted Stock Units N/A | 2.20K | — |
| Total | 2.20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$671.5K
5/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.20K
Market value
$150.7K
6/24/2026
Total
Units
12.20K
Value
$822.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2026 | 10K | $671.5K | — | Completed |
| Planned — Approximate Date | ||||
6/24/2026 | 2.20K | $150.7K | NASDAQ | Planned |
| Total | 12.20K | $822.2K | ||